Pages that link to "Q40418493"
The following pages link to Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro (Q40418493):
Displaying 27 items.
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon (Q27002288) (← links)
- Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses (Q28219525) (← links)
- NF-kappaB and IKK as therapeutic targets in cancer (Q28297985) (← links)
- The influence of Cox-2 and bioactive lipids on hematological cancers (Q33688673) (← links)
- Apoptotic effects of two COX-2 inhibitors on breast adenocarcinoma cells through COX-2 independent pathway. (Q35228956) (← links)
- Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac (Q35637500) (← links)
- Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells (Q36393246) (← links)
- Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways (Q36439206) (← links)
- Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression (Q36637905) (← links)
- Prevention of breast cancer: current state of the science and future opportunities (Q36654338) (← links)
- Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise (Q37239890) (← links)
- Eicosanoids in inflammation and cancer: the role of COX-2. (Q37754720) (← links)
- The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies (Q38183889) (← links)
- Reflux composition influences the level of NF-κB activation and upstream kinase preference in oesophageal adenocarcinoma cells (Q38984466) (← links)
- Niflumic acid affects store-operated Ca(2+)-permeable (SOC) and Ca (2+)-dependent K (+) and Cl (-) ion channels and induces apoptosis in K562 cells (Q38991887) (← links)
- Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway (Q39010100) (← links)
- Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents. (Q39189510) (← links)
- Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells (Q39359313) (← links)
- Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways (Q39832622) (← links)
- The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent (Q40103405) (← links)
- Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro (Q40211117) (← links)
- Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism (Q40311829) (← links)
- Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report (Q41067113) (← links)
- Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2. (Q42316726) (← links)
- The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway (Q46718510) (← links)
- Induction of apoptosis in K562 cells by jolkinolide B. (Q50472696) (← links)
- Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (Q90850871) (← links)